Literature DB >> 17848071

Poxviruses and the passive quest for novel hosts.

R L Regnery1.   

Abstract

Poxviruses are famous, or infamous, as agents of disease introduced into novel host species and between populations of the same species. This discussion concerns selected examples of poxviruses associated with vertebrate infections, i.e., the Chordopoxvirus subfamily of the family Poxviridae. Brief note is made of examples of members of the genera Leporipoxvirus and Parapoxvirus-like agents that have been recognized to have significant trans-host species impact. The remaining bulk of the discussion involves examples of members of the genus Orthopoxvirus, which are known to be (have been) involved with human disease, and their zoonotic origins.

Entities:  

Mesh:

Year:  2007        PMID: 17848071     DOI: 10.1007/978-3-540-70962-6_14

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  3 in total

1.  Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5.

Authors:  Michael H Matho; Matt Maybeno; Mohammed Rafii-El-Idrissi Benhnia; Danielle Becker; Xiangzhi Meng; Yan Xiang; Shane Crotty; Bjoern Peters; Dirk M Zajonc
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.

Authors:  Chad Myskiw; Janilyn Arsenio; Craig Hammett; Rebekah van Bruggen; Yvon Deschambault; Nicole Beausoleil; Shawn Babiuk; Jingxin Cao
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

3.  Serologic evidence for novel poxvirus in endangered red Colobus monkeys, Western Uganda.

Authors:  Tony L Goldberg; Colin A Chapman; Kenneth Cameron; Tania Saj; William B Karesh; Nathan D Wolfe; Scott W Wong; Melissa E Dubois; Mark K Slifka
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.